Zebranie naukowe 12.10.2026
Osoba prowadząca: dr inż. Katarzyna Popiołek-Barczyk
Tytuł prezentacji:
„Turning the enemy into an ally: Can Histamine H3 Receptor Antagonists Change the Rules of Chronic Pain Treatment?„
Proponowana literatura:
-
Maciuszek M, Białoń M, Królewski M, Noworyta K, Fiocchi NA, Lopes FB, Starowicz K, Gouveia WL, Lima LM, Fernandes JPS, Popiolek-Barczyk K. Preclinical characterization of the efficacy and safety of histamine H3 receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment. Eur J Pharmacol. 2026 Oct 28;1034:179265. doi: 10.1016/j.ejphar.2026.179265.
- Degutis M, Łażewska D, Barut J, Białoń M, Latacz G, Szczepańska K, Pietruś W, Werner T, Karcz T, Stark H, Kreiner G, Kieć-Kononowicz K, Starowicz K, Popiolek-Barczyk K. Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation. Biomed Pharmacother (2025) doi: 10.1016/j.biopha.2025.117850.
- Popiolek-Barczyk K, Łażewska D, Latacz G, Olejarz A, Makuch W, Stark H, Kieć-Kononowicz K, Mika J. „Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse” Br J Pharmacol. (2018) doi: 10.1111/bph.14185